Description

CJC-1295 (Growth Hormone Releasing Hormone Analog)

CJC-1295 is a synthetic peptide and analog of Growth Hormone Releasing Hormone (GHRH). It is designed to stimulate the pituitary gland to release growth hormone (GH) and increase Insulin-like Growth Factor 1 (IGF-1) levels. Unlike natural GHRH, CJC-1295 has been modified with a Drug Affinity Complex (DAC) to significantly extend its half-life and duration of action.

Research Properties:

Growth Hormone Stimulation: Studied for its ability to elevate growth hormone secretion and IGF-1 levels.
Muscle & Tissue Research: Investigated for its potential effects on muscle growth, recovery, and body composition.
Metabolic Effects: Researched for possible roles in fat metabolism and overall metabolic function.
Anti-Aging & Recovery: Explored in studies related to tissue repair, sleep quality, and age-related decline.

Administration in Research:

Subcutaneous injection
Typically studied in evening or early morning administrations

For Research Use Only. Not for human consumption. CJC-1295 is intended strictly for laboratory research and in-vitro experimentation.

CORE FEATURES

CJC-1295 with DAC

CJC-1295 NO DAC (Drug Affinity Complex) is a synthetic peptide designed to stimulate the production and release of growth hormone by increasing the half-life of growth hormone-releasing hormone (GHRH) analogs. CJC-1295 is a modification of the first 29 amino acids of Growth Hormone Releasing Hormone. This modification allows for extended activity, resulting in more sustained and stable levels of growth hormone secretion.

Research Applications

CJC-1295 NO DAC is widely studied for its potential role in:

Enhancing protein synthesis and cellular growth.
Promoting recovery in tissue repair and regeneration studies.
Supporting metabolic research related to fat loss and lean muscle preservation.
Investigating anti-aging mechanisms through improved growth hormone levels.

Key Features

Shorter half-life in the bloodstream due to NO DAC technology.
Improved stability for long-term studies.
Designed for in-vitro research purposes only.

Important Note:

CJC-1295 NO DAC is strictly intended for laboratory research and in-vitro experimentation. It is not for human or animal use. This product is not FDA-approved for the diagnosis, treatment, prevention, or cure of any disease or condition.